Tuesday, Feb 24th
Last update10:45:12 PM GMT
Drug companies are blocking or delaying the entry of cheaper generic medicines into the EU, pushing up medicine bills, the European Commission has said.
Their actions cost EU healthcare providers 3bn euros ($3.9bn; £2.5bn) in savings between 2000 and 2007, it said.
 The Food and Drug Administration Monday unveiled the details of a new policy designed to make... |
| ||
 As marijuana use among teens has grown in the past decade, researchers have been trying to... |
 NYU Langone Health, one of New York City’s major hospital networks, announced this week that it... |
